KAYLA ZEIGLER: Open Payments
NPI 1013348465 · MONROEVILLE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$308 in 9 payments from 8 companies in 2025. Trend: 2023 $26 · 2024 $211 · 2025 $308
Food & beverage: $308
| Company | Payments | Amount |
|---|---|---|
| Vantive US Healthcare LLC | 1 | $122 |
| AstraZeneca Pharmaceuticals LP | 2 | $39 |
| Vifor Pharma, Inc. | 1 | $28 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $27 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $25 |
| Otsuka America Pharmaceutical, Inc. | 1 | $25 |
| Lilly USA, LLC | 1 | $21 |
| Ardelyx, Inc. | 1 | $21 |
Products named: Renal - Acute, FARXIGA, Veltassa, Kerendia, JYNARQUE, MOUNJARO, IBSRELA.
Industry payments across PA — which companies pay providers there.
